July 25, 2022 DalCor Pharmaceuticals announced the results of the dal-GenE Phase 3 cardiovascular precision medicine outcomes trial with publication of ‘Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial’ in the European Heart Journal.1 

July 25, 2022 —  iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the 

July 22, 2022 —  Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that David Roman has been appointed President and Chief Executive Officer, and member of the Board of Directors, effective immediately.

July 22, 2022 —  HeartFlow, Inc., the leader in revolutionizing precision heart care, released two datasets utilizing its HeartFlow AI-based Plaque technology* (referred in below as “

July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is estimated to reach $1,621 million by 2030, growing at a CAGR of 9.49% during the forecast period (2022–2030). North America acquires the largest position in the market and is expected to grow at a CAGR of 9.32% by 2030. 

July 21, 2022 — Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announced that its joint venture, Cathbot, established in 2020 with MicroPort through its robotic subsidiary MedBot, has enrolled the last patient in its clinical st

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first pati

July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and heart failure, announced the completion of enrollment in its Phase 2a SAHARA proof-of-concept study using its first-generation DSR product (“DSR 1.0”) as treatment for congestive heart failure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now